Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand access soon.

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Curious about Ozempic benefits? Here’s who could benefit from using these medications—and why they’re not just for weight ...

The high monthly costs of GLP-1s — ranging from $1,000 to $1,500 — are placing considerable financial pressure on healthcare ...

Locally produced versions of drugs like Semaglutide are helpful for patients with obesity and diabetes, but unprescribed use raises concerns ...

There's a nasty aroma coming from Harvey Jones's Self-Invested Personal Pension. These five UK shares are to blame. Should he ...

Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect ...

A Trending Plant-Based Formula Targets the Root Causes of Blood Sugar Instability and Stubborn Weight Gain-Without Stimulants ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Denmark's Novo Nordisk faces mounting pressure — from cheap copycats to US tariff threats — putting its weight-loss empire at ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.